Edition:
United States

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

1.29USD
22 Jun 2018
Change (% chg)

$0.04 (+3.20%)
Prev Close
$1.25
Open
$1.25
Day's High
$1.31
Day's Low
$1.23
Volume
65,639
Avg. Vol
32,282
52-wk High
$3.69
52-wk Low
$1.03

Chart for

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $28.14
Shares Outstanding(Mil.): 21.82
Dividend: --
Yield (%): --

Financials

  VICL.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -1.06 -- --
ROI: -32.55 -5.25 13.10
ROE: -32.55 -6.83 15.09

BRIEF-Vical Reports Q1 Loss Per Share $0.29

* VICAL REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS

May 03 2018

BRIEF-Vical Reports Q4 Loss Per Share Of $0.21

* VICAL REPORTS FOURTH QUARTER 2017 FINANCIAL AND OPERATIONAL RESULTS

Mar 15 2018

BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs

* VICAL ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON HSV-2 AND ANTIFUNGAL CLINICAL PROGRAMS

Jan 30 2018

BUZZ-Vical: Falls as herpes vaccine fails late-stage trial

** Drugmaker's shares fall 27.81 pct to $1.35 - top pct loser among Nasdaq-listed stocks premarket

Jan 22 2018

Competitors

  Price Chg
Sanofi SA (SASY.PA) €69.01 +1.30
Novartis AG (NOVN.S) CHF75.60 +0.10
GlaxoSmithKline plc (GSK.L) 1,546.00 +7.60
AstraZeneca plc (AZN.L) 5,229.00 -26.00
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Pfizer Inc. (PFE.N) $36.51 +0.21
Roche Holding Ltd. (ROG.S) CHF216.45 --
Roche Holding Ltd. (RO.S) CHF223.60 +4.00
Genocea Biosciences Inc (GNCA.OQ) $0.93 -0.06
Agenus Inc (AGEN.OQ) $2.43 -0.07

Earnings vs. Estimates